000 01359 a2200409 4500
005 20250517114641.0
264 0 _c20170130
008 201701s 0 0 eng d
022 _a1791-7530
024 7 _a10.21873/anticanres.11022
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBodner-Adler, Barbara
245 0 0 _aPrognostic Significance of Pre-treatment Serum C-Reactive Protein Level in Patients with Adenocarcinoma of the Uterine Cervix.
_h[electronic resource]
260 _bAnticancer research
_c09 2016
300 _a4691-6 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdenocarcinoma
_xblood
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aBiomarkers, Tumor
_xblood
650 0 4 _aC-Reactive Protein
_xmetabolism
650 0 4 _aCervix Uteri
_xmetabolism
650 0 4 _aDisease-Free Survival
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aLymphatic Metastasis
650 0 4 _aMiddle Aged
650 0 4 _aNeoplasm Staging
650 0 4 _aPrognosis
650 0 4 _aUterine Cervical Neoplasms
_xblood
700 1 _aKimberger, Oliver
700 1 _aSchneidinger, Cora
700 1 _aKölbl, Heinz
700 1 _aBodner, Klaus
773 0 _tAnticancer research
_gvol. 36
_gno. 9
_gp. 4691-6
856 4 0 _uhttps://doi.org/10.21873/anticanres.11022
_zAvailable from publisher's website
999 _c26420499
_d26420499